CCEL

AMEX Cryo-Cell International, Inc.
Oct 12, 2026 · 9:54 PM ET EOD Market Closed

$4.50 ↑ +0.00 (+0.00%) Trading Up from the previous close of $4.50, $0.39 below the day’s high of $4.89

YTD change
+30.82%
vs 20-day SMA
+9.40%
vs 200-day SMA
+25.21%

Price ranges

Previous day
$4.00 $4.47
open $4.00 close $4.36
+$0.36 (+9.00%)
Today
$4.48 $4.89
open $4.75 now $4.50
-$0.25 (-5.26%)
Past week
$3.42 $4.72
from $3.99 now $4.50
+$0.51 (+12.78%)
Past month
$3.42 $4.72
from $4.40 now $4.50
+$0.10 (+2.27%)
This year
$2.72 $4.90
from $3.44 now $4.50
+$1.06 (+30.82%)

Price & Performance

+0.90 (+25.00%) / 6M

$2.77$3.41$4.05$4.69Apr 13Jul 14Oct 12

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good
  • The stock is 64.0% away from all-time highs of $12.50
  • CCEL is up 31% since the beginning of the year
  • CCEL is up 2% over the past 12 months
  • CCEL is up 2% over the past 1 month
  • 0% of all CCEL investors are betting against CCEL
  • Number of investors short CCEL has gone up 37% versus last month

CCEL reads very good: price sits above both the 20- and 200-day averages, short interest is rising month over month, the 12-month move is +1.3%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes
EPS $0.04
Earnings momentum +233.3% Quarterly EPS growth
Quarterly change +233.3%

Valuation

P/E ratio 237.50
Enterprise value $48.6M
Beta 0.51

Balance sheet & scale

IncomeN/A
Revenue$32.0M
Cash$4.4M
Debt$15.8K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeAMEX
Sector Health Care and Social Assistance
Sub Sector Ambulatory Health Care Services
Market cap $36.3M

Cryo-Cell International, Inc. is cord blood bank, which engages in providing stem cell cryopreservation services and advancing regenerative medicine. It operates through the following segments: Cellular Processing and Cryogenic Storage, and Prepacyte CB. The Cellular Processing and Cryogenic Storage segment focuses on the collection and preservation of umbilical cord blood and tissue stem cells for family use. The Prepacyte CB segment refers to the processing technology used to process umbilical cord blood stem cells. The company was founded in 1989 and is headquartered in Oldsmar, FL.

Competitor comparison

TickerCompany PriceChange
CRVL CorVel Corporation $77.92 +0.98%
PRVA Privia Health Group, Inc. $21.45 +2.88%
ALHC Alignment Healthcare, Inc. $8.09 +7.22%
TDOC Teladoc Health, Inc. $5.92 +2.60%
CORBF Global Cord Blood Corporation $0.9510 +0.00%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.